302 filings
Page 2 of 16
SC 14D9/A
TPTX
Turning Point Therapeutics, Inc.
16 Aug 22
Tender offer solicitation (amended)
7:10am
SC TO-T/A
TPTX
Turning Point Therapeutics, Inc.
16 Aug 22
Third party tender offer statement (amended)
7:08am
SC 14D9/A
TPTX
Turning Point Therapeutics, Inc.
9 Aug 22
Tender offer solicitation (amended)
7:07am
SC TO-T/A
TPTX
Turning Point Therapeutics, Inc.
9 Aug 22
Third party tender offer statement (amended)
7:00am
8-K
TPTX
Turning Point Therapeutics, Inc.
8 Aug 22
Turning Point Therapeutics Reports Second-quarter 2022 Financial Results, Provides Operational Updates
4:18pm
4
Tombesi Paolo
29 Jul 22
Turning Point Therapeutics / PAOLO TOMBESI ownership change
4:18pm
SC 14D9/A
TPTX
Turning Point Therapeutics, Inc.
19 Jul 22
Tender offer solicitation (amended)
7:28am
SC TO-T/A
TPTX
Turning Point Therapeutics, Inc.
19 Jul 22
Third party tender offer statement (amended)
7:13am
SC TO-T/A
BMY
Bristol-Myers Squibb Co.
1 Jul 22
Third party tender offer statement (amended)
4:11pm
SC 14D9/A
TPTX
Turning Point Therapeutics, Inc.
1 Jul 22
Tender offer solicitation (amended)
4:01pm
8-K
TPTX
Turning Point Therapeutics, Inc.
24 Jun 22
Entry into a Material Definitive Agreement
9:01am
8-K
TPTX
Turning Point Therapeutics, Inc.
21 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
SC 14D9
TPTX
Turning Point Therapeutics, Inc.
17 Jun 22
Tender offer solicitation
4:46pm
SC TO-T
TPTX
Turning Point Therapeutics, Inc.
17 Jun 22
Third party tender offer statement
4:42pm
SC14D9C
TPTX
Turning Point Therapeutics, Inc.
3 Jun 22
Written communication relating to third party tender offer
5:18pm
8-K
TPTX
Turning Point Therapeutics, Inc.
3 Jun 22
Entry into a Material Definitive Agreement
5:15pm
SC TO-C
TPTX
Turning Point Therapeutics, Inc.
3 Jun 22
Information about tender offer
5:15pm
SC14D9C
TPTX
Turning Point Therapeutics, Inc.
3 Jun 22
Written communication relating to third party tender offer
9:05am
8-K
TPTX
Turning Point Therapeutics, Inc.
3 Jun 22
Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
9:00am